From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease
Journal of Computational Chemistry · 2025
DOI: 10.1002/jcc.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computational Chemistry, 2025. Verfasst von Kunal Bhattacharya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Royal School of Pharmacy, The Assam Royal Global University, Guwahati, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Antipsychotic Agents, Drug Repositioning, Phosphodiesterase 5 Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Phosphodiesterase 5 (PDE5) inhibitors have shown great potential in treating Alzheimer's disease by improving memory and cognitive function. In this study, we evaluated fluspirilene, a drug commonly used to treat schizophrenia, as a potential PDE5 inhibitor using computational methods. Molecular docking revealed that fluspirilene binds strongly to PDE5, supported by hydrophobic and aromatic interactions. Molecular dynamics simulations confirmed that the fluspirilene–PDE5 complex is stable and maintains its structural integrity over time. Binding energy calculations further highlighted favorable interactions, indicating that the drug forms a strong and stable bond with PDE5. Additional analyses, including studies of protein dynamics and energy landscape mapping, revealed how the drug interacts dynamically with PDE5, adapting to different conformations and maintaining stability. These findings suggest that fluspirilene may modulate PDE5 activity, potentially offering therapeutic benefits for Alzheimer's disease. This study provides strong evidence for repurposing fluspirilene as a treatment for Alzheimer's and lays the foundation for further experimental and clinical investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal School of Pharmacy, The Assam Royal Global University, Guwahati, India.
- Department of Pharmaceutical Chemistry, Pratiksha Institute of Pharmaceutical Sciences, Guwahati, India.
- Department of Pharmacology, Himalayan Pharmacy Institute, Majhitar, India.
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
- Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, New South Wales, Australia.
ORCID-Profile: Kunal Bhattacharya
Zitieren
APA
Bhattacharya, K., Bhattacharjee, A., Chakraborty, M., Das, D., & Paudel, K. R. (2025). From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease. Journal of Computational Chemistry. https://doi.org/10.1002/jcc.70029
Vancouver
Bhattacharya K, Bhattacharjee A, Chakraborty M, Das D, Paudel KR. From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease. Journal of Computational Chemistry. 2025. doi:10.1002/jcc.70029
BibTeX
@article{Bhattacharya2025,
author = {Bhattacharya, Kunal and Bhattacharjee, Atanu and Chakraborty, Manodeep and Das, Dibyajyoti and Paudel, Keshav Raj},
title = {From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease},
journal = {Journal of Computational Chemistry},
year = {2025},
doi = {10.1002/jcc.70029}
}
EUVIMED